TITLE

Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups

AUTHOR(S)
Schenkel, Karl; Radun, Doris; Bremer, Viviane; Bocter, Nikolaus; Hamouda, Osamah
PUB. DATE
January 2008
SOURCE
BMC Public Health;2008, Vol. 8 Issue 1, p132
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In Germany, vaccination against hepatitis B is recommended for infants, children and adolescents since 1995 and for specific target groups since 1982. Little is known about knowledge about viral hepatitis and attitudes toward hepatitis B vaccination-factors likely to influence vaccine uptake. Methods: In order to estimate vaccination coverage in adult target groups and in the overall adult population and to assess knowledge and attitudes, we conducted a nationwide cross-sectional telephone survey among 412 persons in November 2004. We defined participants as being vaccinated if they reported at least one previous vaccination against hepatitis B. Results: Vaccination coverage (vc) standardised for age, sex and residence was 29.6% in the general population and 58.2% in target groups for hepatitis B vaccination. Particular gaps in vaccine coverage were detected among health care workers (vc: 69.5%) and chronically ill persons (vc: 22.0%). Knowledge on risk factors and transmission was far below expectations, whereas the acceptance of vaccination in the majority of the population (79.0%) was good. Conclusion: We conclude that educational measures could lead to a higher vaccination uptake in adult target groups.
ACCESSION #
51485923

 

Related Articles

  • ANSWERS TO QUESTIONS IN PREVIOUS ISSUE.  // International Journal of STD & AIDS;Jan1998, Vol. 9 Issue 1, p8 

    The article presents questions and answers related to Human Immunodeficiency Virus (HIV) infection and Hepatitis infection. One of the questions is related to the Hepatitis B Virus Infection and HIV infection. Another question is related to the HIV infection and Hepatitis C Virus infection....

  • Hepatitis C and E in the Eastern Mediterranean Region.  // Bulletin of the World Health Organization;1995, Vol. 73 Issue 5, p714 

    Reports on the prevalence of viral hepatitis in the Eastern Mediterranean Region. Classification of viral hepatitis infections; Clinical features and modes of transmission of hepatitis C virus (HCV); Prevention and control of HCV; Clinical features of viral hepatitis E; Prevention and control;...

  • Sources of Hepatitis E Virus Genotype 3 in the Netherlands. Rutjes, Saskia A.; Lodder, Willemijn J.; Lodder-Verschoor, Froukje; Van den Berg, Harold H. J. L.; Vennema, Harry; Duizer, Erwin; Koopmans, Marion; Husman, Ana Maria de Roda // Emerging Infectious Diseases;Mar2009, Vol. 15 Issue 3, p381 

    Non-travel-related hepatitis E virus (HEV) genotype 3 infections in persons in the Netherlands may have a zoonotic, foodborne, or water-borne origin. Possible reservoirs for HEV transmission by water, food, and animals were studied. HEV genotype 3/open reading frame 2 sequences were detected in...

  • Ocular Vaccinia: A Consequence of Unrecognized Contact Transmission. Montgomery, Jay R.; Carroll, Robert B.; McCollum, Andrea M. // Military Medicine;Jun2011, Vol. 176 Issue 6, p699 

    A patient developed severe ocular vaccinia via autoinoculation after acquiring unrecognized contact-transmitted vaccinia from wrestling with vaccinated members of his unit. This case highlights both the need to reinforce infection-control measures among vaccinees and the need for providers to be...

  • News.  // Clinical Infectious Diseases;7/1/2010, Vol. 51 Issue 1, pi 

    The article offers news briefs related to issues on infectious diseases. The Fluzone High-Dose influenza vaccine with an increased amount of virus hemagglutinin antigen was licensed by the Food and Drug Administration (FDA) for persons aged 65 or above. Fans heading for the 2010 World Cup in...

  • The potential for measles transmission in England. Yoon Hong Choi; Nigel Gay; Fraser, Graham; Ramsay, Mary // BMC Public Health;2008, Vol. 8 Issue 1, p338 

    Background: Since the schools vaccination campaign in 1994, measles has been eliminated from England. Maintaining elimination requires low susceptibility levels to keep the effective reproduction number R below 1. Since 1995, however, MMR coverage in two year old children has decreased by more...

  • PLoS ONE: Biologists produce potential malarial vaccine from algae.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article informs that a vaccine has been developed from algal extract for preventing the transmission of the malarial parasite.

  • A High Prevalence of Serum GN Virus C/Hepatitis G Virus RNA in Children with and without Liver... Halasz, Robert; Fischler, Bjorn; Nemeth, Antal; Lundholm, Suzana; Sallberg, Matti // Clinical Infectious Diseases;3/1/1999, Vol. 28 Issue 3, p537 

    Investigates the prevalence and possible routes of transmission of GB virus C/hepatitis G virus (GBV-C/HGV) in children with or without liver disease. Establishment of GBV-C/HGV early in life; Rate of GBV-C/HGV RNA seropositivity in children; Advantage of testing patients without liver disease...

  • Epidemiology and Natural History of Hepatitis C Virus Infection in Injection Drug Users: Implications for Treatment. Sulkowski, Mark S.; Thomas, David L. // Clinical Infectious Diseases;4/15/2005 Supplement, Vol. 40, pS263 

    Effective methods to diminish the burden of hepatitis C virus (HCV) infection among injection drug users (IDUs) require consideration of the epidemiology and natural history of both hepatitis C and drug use. Most HCV infections are due to injection drug use, and most IDUs have HCV infection. In...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics